Background
==========

Genomes of the model bacterium, *Escherichia coli*, exhibit high plasticity caused by gene gain/loss via pathoadaptive mutations, genetic rearrangement, and horizontal gene transfer \[[@B1],[@B2]\]. This genetic variability is also translated into a remarkable phenotypic and pathotypic diversity: while some *E. coli*strains normally inhabit the mammalian colon, other pathotypes cause a wide range of intestinal and extraintestinal diseases that include mild intestinal disturbance but also severe urinary tract infections and outbreaks of shigellosis-like dysentery or cholera-like watery diarrhea \[[@B1]\]. In this study, we focus on enterotoxigenic *E. coli*(ETEC), one of the world\'s deadliest infectious agents, which also represents a serious public health in Egypt\'s rural areas. Our aim is to integrate multiple bioinformatics tools to determine horizontally transferred, pathotype-specific signature genes as targets for specific, high-throughput molecular diagnostic tools and reverse vaccinology screens.

Methods and results
===================

To estimate the extent of horizontal gene transfer in ETEC, we used a combination of bioinformatics tools, including GC%, comparative genometrics analysis \[[@B3]\], and web-based prediction of pathogenicity islands via IslandPath <http://www.pathogenomics.sfu.ca/islandpath>\[[@B4]\]. Because *E. coli*strains are typically polylysogenic \[[@B5]\], we used the ACLAME Prophinder tool <http://aclame.ulb.ac.be/Tools/Prophinder>\[[@B6]\] to predict complete or rudimentary prophages scattered within the ETEC genome. To determine ETEC pathotype-specific genes or signature genes, we used comparative genomic tools available in the National Microbial Pathogen Data Resource (NMPDR) platform <http://www.nmpdr.org>, including the Signature Genes Tool and the Homolog Spreadsheet Tool \[[@B7]\]. We identified 128 genes that differentiate this pathotype from other *E. coli*strains, based on bidirectional-best-hit signature analysis. We also identified 94 genes that are characteristic to two closely related strains (24377A and 2348/69). Many of the ETEC-specific genes were mapped to prophages, prophage-like elements, and other pathogenicity islands; however, some of these signature genes, e.g., ORFs 21--39 in strain 24377A, seem to be rather lost in other *E. coli*strains (as they are conserved among other enterobacteria, e.g., *Shigella*and *Salmonella*). Our ongoing studies are testing some of these ETEC-specific genes as targets for multiplex PCR amplification to develop a rapid diagnostic typing method. Future studies will analyze the surface-association and antigenicity of these signature gene products as a first step in a reverse vaccinology strategy to develop novel ETEC vaccines.
